Market Overview:
The global fine pharmaceutical chemicals market is expected to grow at a CAGR of 6.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing demand for small molecules and big molecules in various applications such as non-proprietary drugs and proprietary drugs. In terms of region, North America is expected to lead the global fine pharmaceutical chemicals market during the forecast period, followed by Europe and Asia Pacific. The growth in these regions can be attributed to factors such as rising demand for generic drugs, increasing R&D expenditure by pharma companies, and growing awareness about healthcare among consumers.
Product Definition:
Fine Pharmaceutical Chemicals are chemicals that are used in the manufacture of pharmaceutical products. They include active ingredients, excipients, and intermediates. The use of fine pharmaceutical chemicals is important because they help to ensure the quality and safety of pharmaceutical products.
Big Molecules:
Big molecules are large polymers or macromolecules. They can be further classified as small molecules and non-small molecules based on their size. Big Molecules have a higher boiling point, they are more viscous & less volatile, and have a lower surface tension than smaller ones do.
Small Molecules:
Small molecules are the chemical compounds, which have a molecular weight below 100 and commonly used in fine pharmaceutical chemicals. Small molecules can also be defined as any organic compound that has a molecular weight less than 1000. The most common types of small molecule products include flavors & fragrances, pigments & additives, active pharmaceutical ingredients (API), and finished dose formulations such as tablets or capsules.
Application Insights:
Non-proprietary drugs accounted for the largest share of over 70.0% in 2017. Non-proprietary drugs are those where both the manufacturer and retailer have knowledge of ingredients, dosage, and route of administration as well as information regarding safety and effectiveness. This type includes aspirin, sodium bicarbonate (baking soda), glucose tablets, vitamin C supplements & cough syrups among others.
Regional Analysis:
Asia Pacific dominated the global market in 2017. The region is expected to maintain its position through the forecast period owing to high product demand from various industries, such as healthcare and pharmaceuticals. China and India are among the largest markets for fine pharmaceutical chemicals in this region. Factors such as rapidly growing medical tourism industry, increasing healthcare expenditure by governments along with rising awareness about advanced medicines are driving growth of these markets over the forecast period.
Growth Factors:
- Increasing demand for generic drugs: The global market for generic drugs is expected to grow at a CAGR of 9.5% from 2016 to 2021. This growth can be attributed to the increasing demand for generics due to their lower prices and rising healthcare costs. The Fine Pharmaceutical Chemicals market is expected to benefit from this trend as it supplies key ingredients used in the manufacture of generic drugs.
- Rising prevalence of chronic diseases: The prevalence of chronic diseases such as cancer, diabetes, and heart disease is on the rise globally due to changing lifestyles and aging populations. This is leading to an increase in the demand for pharmaceuticals, which in turn is driving growth in the Fine Pharmaceutical Chemicals market.
- Growing investments in R&D: Pharmaceutical companies are investing heavily in R&D with a view to developing new products that can address unmet medical needs and tap into growing markets such as China and India . This is resulting in increased spending on fine chemicals by pharmaceutical companies, thereby driving growth in the Fine Pharmaceutical Chemicals market .
Scope Of The Report
Report Attributes
Report Details
Report Title
Fine Pharmaceutical Chemicals Market Research Report
By Type
Big Molecules, Small Molecules
By Application
Non Proprietary Drugs, Poprietary Drugs
By Companies
Abbott, Akzo Nobel, Albemarle Corporation, AstraZeneca, BASF, Boehringer Ingelheim, Clariant, Eastman Chemical, Evonik Industries, GlaxoSmithKlein, Lonza Group, Merck and co., Roche, Royal DSM, The Dow Chemical Company
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
239
Number of Tables & Figures
168
Customization Available
Yes, the report can be customized as per your need.
Global Fine Pharmaceutical Chemicals Market Report Segments:
The global Fine Pharmaceutical Chemicals market is segmented on the basis of:
Types
Big Molecules, Small Molecules
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Non Proprietary Drugs, Poprietary Drugs
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Abbott
- Akzo Nobel
- Albemarle Corporation
- AstraZeneca
- BASF
- Boehringer Ingelheim
- Clariant
- Eastman Chemical
- Evonik Industries
- GlaxoSmithKlein
- Lonza Group
- Merck and co.
- Roche
- Royal DSM
- The Dow Chemical Company
Highlights of The Fine Pharmaceutical Chemicals Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Big Molecules
- Small Molecules
- By Application:
- Non Proprietary Drugs
- Poprietary Drugs
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Fine Pharmaceutical Chemicals Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Some of the major players in the fine pharmaceutical chemicals market are Abbott, Akzo Nobel, Albemarle Corporation, AstraZeneca, BASF, Boehringer Ingelheim, Clariant, Eastman Chemical, Evonik Industries, GlaxoSmithKlein, Lonza Group, Merck and co., Roche, Royal DSM, The Dow Chemical Company.
The fine pharmaceutical chemicals market is expected to register a CAGR of 6.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Fine Pharmaceutical Chemicals Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Fine Pharmaceutical Chemicals Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Fine Pharmaceutical Chemicals Market - Supply Chain
4.5. Global Fine Pharmaceutical Chemicals Market Forecast
4.5.1. Fine Pharmaceutical Chemicals Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Fine Pharmaceutical Chemicals Market Size (000 Units) and Y-o-Y Growth
4.5.3. Fine Pharmaceutical Chemicals Market Absolute $ Opportunity
5. Global Fine Pharmaceutical Chemicals Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Fine Pharmaceutical Chemicals Market Size and Volume Forecast by Type
5.3.1. Big Molecules
5.3.2. Small Molecules
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Fine Pharmaceutical Chemicals Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Fine Pharmaceutical Chemicals Market Size and Volume Forecast by Application
6.3.1. Non Proprietary Drugs
6.3.2. Poprietary Drugs
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Fine Pharmaceutical Chemicals Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Fine Pharmaceutical Chemicals Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Fine Pharmaceutical Chemicals Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Fine Pharmaceutical Chemicals Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Fine Pharmaceutical Chemicals Demand Share Forecast, 2019-2026
9. North America Fine Pharmaceutical Chemicals Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Fine Pharmaceutical Chemicals Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Fine Pharmaceutical Chemicals Market Size and Volume Forecast by Application
9.4.1. Non Proprietary Drugs
9.4.2. Poprietary Drugs
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Fine Pharmaceutical Chemicals Market Size and Volume Forecast by Type
9.7.1. Big Molecules
9.7.2. Small Molecules
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Fine Pharmaceutical Chemicals Demand Share Forecast, 2019-2026
10. Latin America Fine Pharmaceutical Chemicals Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Fine Pharmaceutical Chemicals Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Fine Pharmaceutical Chemicals Market Size and Volume Forecast by Application
10.4.1. Non Proprietary Drugs
10.4.2. Poprietary Drugs
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Fine Pharmaceutical Chemicals Market Size and Volume Forecast by Type
10.7.1. Big Molecules
10.7.2. Small Molecules
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Fine Pharmaceutical Chemicals Demand Share Forecast, 2019-2026
11. Europe Fine Pharmaceutical Chemicals Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Fine Pharmaceutical Chemicals Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Fine Pharmaceutical Chemicals Market Size and Volume Forecast by Application
11.4.1. Non Proprietary Drugs
11.4.2. Poprietary Drugs
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Fine Pharmaceutical Chemicals Market Size and Volume Forecast by Type
11.7.1. Big Molecules
11.7.2. Small Molecules
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Fine Pharmaceutical Chemicals Demand Share, 2019-2026
12. Asia Pacific Fine Pharmaceutical Chemicals Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Fine Pharmaceutical Chemicals Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Fine Pharmaceutical Chemicals Market Size and Volume Forecast by Application
12.4.1. Non Proprietary Drugs
12.4.2. Poprietary Drugs
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Fine Pharmaceutical Chemicals Market Size and Volume Forecast by Type
12.7.1. Big Molecules
12.7.2. Small Molecules
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Fine Pharmaceutical Chemicals Demand Share, 2019-2026
13. Middle East & Africa Fine Pharmaceutical Chemicals Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Fine Pharmaceutical Chemicals Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Fine Pharmaceutical Chemicals Market Size and Volume Forecast by Application
13.4.1. Non Proprietary Drugs
13.4.2. Poprietary Drugs
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Fine Pharmaceutical Chemicals Market Size and Volume Forecast by Type
13.7.1. Big Molecules
13.7.2. Small Molecules
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Fine Pharmaceutical Chemicals Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Fine Pharmaceutical Chemicals Market: Market Share Analysis
14.2. Fine Pharmaceutical Chemicals Distributors and Customers
14.3. Fine Pharmaceutical Chemicals Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Abbott
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Akzo Nobel
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Albemarle Corporation
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. AstraZeneca
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. BASF
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Boehringer Ingelheim
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Clariant
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Eastman Chemical
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Evonik Industries
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. GlaxoSmithKlein
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. Lonza Group
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. Merck and co.
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. Roche
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. Royal DSM
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. The Dow Chemical Company
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
